Teaching Obesity Treatment Options to Adult Learners Trial
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 3/9/2019 |
| Start Date: | April 1, 2019 |
| End Date: | June 30, 2023 |
| Contact: | Sally A Jolles, MA |
| Email: | Sally.Jolles@va.gov |
| Phone: | (608) 280-7222 |
A Randomized Pilot Study of a Video-based Obesity Educational Intervention (CDA 15-060)
Obesity is the second leading cause of death in the U.S. The treatment of obesity and its
related health issues, including cardiovascular disease and diabetes, exceeds $150 billion
annually. "Morbidly" or "severely" obese patients - defined by a body mass index [BMI] of >35
kg/m2 or greater - are especially high risk for serious complications due to their weight.
Within the Veterans Health Administration (VA) system, nearly 600,000 patients are severely
obese. These Veterans create significant costs for the VA system, experience poorer quality
of life, and have shortened lifespans. Bariatric surgery is the most effective treatment for
severe obesity for weight loss, resolving weight-related health issues, and quality of life.
Bariatric surgery is supported as a treatment option by many national societies, including
those representing primary care and endocrinology. However, less than 1% of Veterans who
qualify for bariatric surgery undergo it. Reasons for low utilization are unclear, although
the investigators' preliminary research suggests that there are various patient, provider and
system level barriers to severe obesity care. The goal of this study is to pilot-test an
educational video that aligns patient preferences with treatment options to improve the care
that severely obese Veterans receive.
related health issues, including cardiovascular disease and diabetes, exceeds $150 billion
annually. "Morbidly" or "severely" obese patients - defined by a body mass index [BMI] of >35
kg/m2 or greater - are especially high risk for serious complications due to their weight.
Within the Veterans Health Administration (VA) system, nearly 600,000 patients are severely
obese. These Veterans create significant costs for the VA system, experience poorer quality
of life, and have shortened lifespans. Bariatric surgery is the most effective treatment for
severe obesity for weight loss, resolving weight-related health issues, and quality of life.
Bariatric surgery is supported as a treatment option by many national societies, including
those representing primary care and endocrinology. However, less than 1% of Veterans who
qualify for bariatric surgery undergo it. Reasons for low utilization are unclear, although
the investigators' preliminary research suggests that there are various patient, provider and
system level barriers to severe obesity care. The goal of this study is to pilot-test an
educational video that aligns patient preferences with treatment options to improve the care
that severely obese Veterans receive.
Obesity is the second leading cause of death in the U.S. The treatment of obesity and its
related comorbidities, including cardiovascular disease and diabetes, exceeds $150 billion
annually. "Morbidly" or "severely" obese patients - defined by a body mass index [BMI] of >35
kg/m2 or greater - are especially high risk for serious complications due to the metabolic
and physiologic derangements that occur with severe obesity. Within the Veterans Health
Administration (VA) system, nearly 600,000 patients are severely obese. These Veterans exert
significant costs on the VA system, experience poorer quality of life, and have shortened
lifespans. Bariatric surgery is the most effective treatment for severe obesity for weight
loss, comorbidity resolution, and quality of life. Bariatric surgery is supported as a
treatment option by many national societies, including those representing primary care and
endocrinology. However, less than 1% of Veterans who qualify for bariatric surgery undergo
it. Reasons for low utilization are unclear, although the investigators' preliminary research
suggests that there are various patient, provider and system level barriers to severe obesity
care. The goal of this study is to pilot-test an educational video that aligns patient
preferences with treatment options to optimize the care that severely obese Veterans receive.
related comorbidities, including cardiovascular disease and diabetes, exceeds $150 billion
annually. "Morbidly" or "severely" obese patients - defined by a body mass index [BMI] of >35
kg/m2 or greater - are especially high risk for serious complications due to the metabolic
and physiologic derangements that occur with severe obesity. Within the Veterans Health
Administration (VA) system, nearly 600,000 patients are severely obese. These Veterans exert
significant costs on the VA system, experience poorer quality of life, and have shortened
lifespans. Bariatric surgery is the most effective treatment for severe obesity for weight
loss, comorbidity resolution, and quality of life. Bariatric surgery is supported as a
treatment option by many national societies, including those representing primary care and
endocrinology. However, less than 1% of Veterans who qualify for bariatric surgery undergo
it. Reasons for low utilization are unclear, although the investigators' preliminary research
suggests that there are various patient, provider and system level barriers to severe obesity
care. The goal of this study is to pilot-test an educational video that aligns patient
preferences with treatment options to optimize the care that severely obese Veterans receive.
Inclusion Criteria:
- Veterans scheduled to attend an in-person MOVE! visit led by a dietitian at the main
VA hospital.
Exclusion Criteria:
- No access to telephone, doesn't speak English as their primary language, has undergone
bariatric surgery
We found this trial at
1
site
Madison, Wisconsin 53705
Principal Investigator: Luke M Funk
Phone: 608-280-7222
Click here to add this to my saved trials
